During the past decade, Cardiovascular Associates Ltd. conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 6 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cardiovascular Associates Ltd." #1 sponsor was "Abbott Medical Devices" with 2 trials, followed by "Boehringer Ingelheim" with 1 trials sponsored, "Duke University" with 1 trials sponsored, "HealthCore-NERI" with 1 trials sponsored and "NYU Langone Health" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cardiovascular Associates Ltd." #1 collaborator was "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Albany Stratton VA Medical Center" with 1 trials as a collaborator, "Cedars-Sinai Medical Center" with 1 trials as a collaborator, "Columbia University" with 1 trials as a collaborator and "Duke University" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "Cardiovascular Associates Ltd." are "Heart Failure" (3 trials), "Cardiovascular Diseases" (2 trials), "Heart Diseases" (2 trials), "Atrial Fibrillation" (1 trials) and "Congestive Heart Failure" (1 trials). Many other conditions were trialed in "Cardiovascular Associates Ltd." in a lesser frequency.

Most popular intervention types in "Cardiovascular Associates Ltd." are "Drug" (4 trials), "Device" (2 trials), "Behavioral" (1 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Biomarker-guided care NT-proBNP" (1 trials), "Implantation of a QuickFlex® μ Model 1258T LV Lead" (1 trials), "Lifestyle" (1 trials) and "MCC-135" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cardiovascular Associates Ltd." are 8 trials for "All" genders.

Currently, there are NaN active trials in "Cardiovascular Associates Ltd.". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Cardiovascular Associates Ltd., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cardiovascular Associates Ltd., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".